Why the study?
Does radiotherapy provide effective radical or palliative management for patients with cardiac involvement by lymphomas and leukemias?
Does radiotherapy provide effective radical or palliative management for patients with cardiac involvement by lymphomas and leukemias?
Radiotherapy can be a valuable modality for both radical and palliative management of cardiac involvement by lymphomas and leukemias, particularly for controlling pericardial effusions.
Answers are grounded in this paper and cite their sources.
May support effusion control in cardiac lymphoma/leukemia; leaves open radiotherapy's role pending prospective data.
Seven patients with cardiac involvement from lymphomas and leukemias who were treated with radiotherapy are presented. Two patients who had pericardial invasion from surrounding mediastinal nodes and whose disease was otherwise confined to the lymphatic system were treated radically. They are alive without evidence of disease at 2 years and one year, respectively. The remaining 5 were treated palliatively. Of these 5, 3 patients had excellent responses. Although significant palliation was not achieved in the other 2 patients because of the widespread nature of their disease, their pericardial effusions were controlled by the radiotherapy. It is felt that radiotherapy can prove valuable in the radical and palliative management of patients with cardiac involvement by lymphomas and leukemias.
No takes yet. Share an insight, caveat, or question.
Terry et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: